Based on the resemblance in the pathological spectrums between fatty liver disease and fatty pancreas disease, it can be extrapolated that FGF21 would similarly exert an inhibitory, protective effect on the fatty pancreas and inflammation-associated PDAC development. Here, FGF21 is linked to fatty liver disease.